Death or profit: Flash, CGM and patient-centricity
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]
CGM
The CGM Royal Rumble – 4 systems face off, one will win…
Back in early October the CGM Royal Rumble kicked off. Four CGM systems, located in their manufacturer recommended locations on the body and using their […]
Nemaura Sugarbeat’s interim home trial results. Are they any good?
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]
Yet another new CGM system – with a MARD of 8.67%… Welcome the POCTech CT-100
***Updated following clarification from the UK Distributor*** Whilst I recently tested and reported back on the Medtrum A6 CGM system, it’s not the only newcomer […]
A month with Medtrum’s A6 CGM
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
Medtrum A6 CGM – A week (or two) in the life
After the initial couple of days with the Medtrum, and the data that was produced, I thought it would be a good idea to provide […]
The Medtrum A6 CGM. Initial impressions on performance…
Following the earlier article on what you get when you buy a Medtrum A6 CGM, let me precipitate this piece by mentioning that it contains […]
The real cost of Time in Range – what it takes to replace Hba1C #ATTD2018
Anyone watching the Twitter feed for the Advanced Technologies and Treatments for Diabetes 2018 conference can’t fail to have noticed that, once again, the answer […]
Taking #OpenAPS to Glastonbury Festival – preparing for 5 days in a field, off-grid and offline
If you hadn’t guessed from the title, I’m off to Glastonbury Festival at the end of June. And I intend to take OpenAPS with me. […]